Endotoxemia, Inflammation, and Atrial Fibrillation

American Journal of Cardiology

Volumn 100, Issue 6, 2007, Pages 986-988

  Boos, Christopher J ^a,b   Lip, Gregory Y H ^a   Jilma, Bernd ^c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b Army Medical Directorate   (United Kingdom)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ENDOTOXEMIA; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PATIENT MONITORING; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; ENDOTOXEMIA; HUMANS; INFLAMMATION; INFUSIONS, INTRAVENOUS; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; NEUTROPHILS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548446296     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.04.039     Document Type: Article

References (24)

1. Boos C.J., Anderson R.A., and Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
2. Roldan V., Marin F., Martinez J.G., Garcia-Herola A., Sogorb F., and Lip G.Y. Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation. Am J Cardiol 95 (2005) 881-882
3. Abdelhadi R.H., Gurm H.S., Van Wagoner D.R., and Chung M.K. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 93 (2004) 1176-1178
4. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol 94 (2004) 508-510
5. Sata N., Hamada N., Horinouchi T., Amitani S., Yamashita T., Moriyama Y., and Miyahara K. C-Reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?. Jpn Heart J 45 (2004) 441-445
6. Dernellis J., and Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25 (2004) 1100-1107
7. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., and Van Wagoner D.R. C-Reactive protein elevation in subjects with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
8. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in subjects with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
9. Boos C.J., Goon P.K., and Lip G.Y. The endothelium, inflammation, and coagulation in sepsis. Clin Pharmacol Ther 79 (2006) 20-22
10. Derhaschnig U., Reiter R., Knobl P., Baumgartner M., Keen P., and Jilma B. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 102 (2003) 2093-2098
11. Mayr F.B., and Jilma B. Coagulation interventions in experimental human endotoxemia. Translational Research 148 (2006) 263-271
12. Fiuza C., and Suffredini A.F. Human models of innate immunity: local and systemic inflammatory responses. J Endotoxin Res 7 (2001) 385-388
13. Jilma B. Safety of endotoxin challenge in healthy volunteers: bradycardia (lett). Intensive Care Med 31 (2005) 496
14. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., et al. American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Europace 8 (2006) 651-745
15. Derhaschnig U., Bergmair D., Marsik C., Schlifke I., Wijdenes J., and Jilma B. Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia. Crit Care Med 32 (2004) 1136-1140
16. Ellinor P.T., Low A., Patton K.K., Shea M.A., and Macrae C.A. C-Reactive protein in lone atrial fibrillation. Am J Cardiol 97 (2006) 1346-1350
17. Nakamura Y., Nakamura K., Fukushima-Kusano K., Ohta K., Matsubara H., Hamuro T., Yutani C., and Ohe T. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res 111 (2003) 137-142
18. Lip G.Y., Patel J.V., Hughes E., and Hart R.G. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 38 (2007) 1229-1237
19. Conway D.S., and Lip G.Y. Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation (lett). Eur Heart J 25 (2004) 1761
20. Crystal E., Connolly S.J., Sleik K., Ginger T.J., and Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 106 (2002) 75-80
21. Zimmer J., Pezzullo J., Choucair W., Southard J., Kokkinos P., Karasik P., Greenberg M.D., and Singh S.N. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol 91 (2003) 1137-1140
22. Bruins P., te Velthuis H., Yazdanbakhsh A.P., Jansen P.G., van Hardevelt F.W., de Beaumont E.M., Wildevuur C.R., Eijsman L., Trouwborst A., and Hack C.E. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
23. Haissaguerre M., Jais P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Metayer P., and Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 (1998) 659-666
24. Watanabe H., Tanabe N., Makiyama Y., Chopra S.S., Okura Y., Suzuki H., Matsui K., Watanabe T., Kurashina Y., and Aizawa Y. ST-segment abnormalities and premature complexes are predictors of new-onset atrial fibrillation: the Niigata preventive medicine study. Am Heart J 152 (2006) 731-735